NewsNew developments on the forefront of intermediate-risk pulmonary embolismAuthor:Eugene Yuriditsky, MD, FCCP, Member-At-LargePublish date: September 4, 2024While systemic anticoagulation is the mainstay therapy, select individuals may benefit from more immediate reperfusion.Read More
